These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31046725)

  • 1. Influenza epidemiology and influenza vaccine effectiveness during the 2016-2017 season in the Global Influenza Hospital Surveillance Network (GIHSN).
    Baselga-Moreno V; Trushakova S; McNeil S; Sominina A; Nunes MC; Draganescu A; Unal S; Koul P; Kyncl J; Zhang T; Kuatbayeva A; Ben-Salah A; Burtseva E; Puig-Barberà J; Díez-Domingo J;
    BMC Public Health; 2019 May; 19(1):487. PubMed ID: 31046725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2012-2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the global influenza hospital surveillance network.
    Puig-Barberà J; Natividad-Sancho A; Launay O; Burtseva E; Ciblak MA; Tormos A; Buigues-Vila A; Martínez-Úbeda S; Sominina A;
    PLoS One; 2014; 9(6):e100497. PubMed ID: 24945510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network.
    Puig-Barberà J; Mira-Iglesias A; Burtseva E; Cowling BJ; Serhat U; Ruiz-Palacios GM; Launay O; Kyncl J; Koul P; Siqueira MM; Sominina A;
    BMC Infect Dis; 2019 May; 19(1):415. PubMed ID: 31088481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season.
    Mira-Iglesias A; López-Labrador FX; Baselga-Moreno V; Tortajada-Girbés M; Mollar-Maseres J; Carballido-Fernández M; Schwarz-Chavarri G; Puig-Barberà J; Díez-Domingo J;
    Euro Surveill; 2019 Aug; 24(31):. PubMed ID: 31387672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.
    Rondy M; Launay O; Puig-Barberà J; Gefenaite G; Castilla J; de Gaetano Donati K; Galtier F; Hak E; Guevara M; Costanzo S; ; Moren A
    Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
    Rondy M; Launay O; Castilla J; Costanzo S; Puig-Barberà J; Gefenaite G; Larrauri A; Rizzo C; Pitigoi D; Syrjänen RK; Machado A; Kurečić Filipović S; Krisztina Horváth J; Paradowska-Stankiewicz I; Marbus S; ; Moren A
    Vaccine; 2017 Aug; 35(34):4298-4306. PubMed ID: 28709555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
    Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN).
    Blyth CC; Macartney KK; Hewagama S; Senenayake S; Friedman ND; Simpson G; Upham J; Kotsimbos T; Kelly P; Cheng AC
    Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.
    Thompson MG; Pierse N; Sue Huang Q; Prasad N; Duque J; Claire Newbern E; Baker MG; Turner N; McArthur C;
    Vaccine; 2018 Sep; 36(39):5916-5925. PubMed ID: 30077480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
    Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.
    Rondy M; Castilla J; Launay O; Costanzo S; Ezpeleta C; Galtier F; de Gaetano Donati K; Moren A
    Hum Vaccin Immunother; 2016 May; 12(5):1217-24. PubMed ID: 27065000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
    Rondy M; Larrauri A; Casado I; Alfonsi V; Pitigoi D; Launay O; Syrjänen RK; Gefenaite G; Machado A; Vučina VV; Horváth JK; Paradowska-Stankiewicz I; Marbus SD; Gherasim A; Díaz-González JA; Rizzo C; Ivanciuc AE; Galtier F; Ikonen N; Mickiene A; Gomez V; Kurečić Filipović S; Ferenczi A; Korcinska MR; van Gageldonk-Lafeber R; ; Valenciano M
    Euro Surveill; 2017 Jul; 22(30):. PubMed ID: 28797322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study.
    Rondy M; Puig-Barbera J; Launay O; Duval X; Castilla J; Guevara M; Costanzo S; de Gaetano Donati K; Moren A
    PLoS One; 2013; 8(4):e59681. PubMed ID: 23565159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
    Rose AMC; Kissling E; Gherasim A; Casado I; Bella A; Launay O; Lazăr M; Marbus S; Kuliese M; Syrjänen R; Machado A; Kurečić Filipović S; Larrauri A; Castilla J; Alfonsi V; Galtier F; Ivanciuc A; Meijer A; Mickiene A; Ikonen N; Gómez V; Lovrić Makarić Z; Moren A; Valenciano M;
    Influenza Other Respir Viruses; 2020 May; 14(3):302-310. PubMed ID: 32022450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
    Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza season.
    Puig-Barberà J; Tormos A; Sominina A; Burtseva E; Launay O; Ciblak MA; Natividad-Sancho A; Buigues-Vila A; Martínez-Úbeda S; Mahé C;
    BMC Public Health; 2014 Jun; 14():564. PubMed ID: 24903737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain.
    Gherasim A; Martínez-Baz I; Castilla J; Pozo F; Larrauri A;
    PLoS One; 2017; 12(6):e0179160. PubMed ID: 28614376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.
    Bellino S; Bella A; Puzelli S; Di Martino A; Facchini M; Punzo O; Pezzotti P; Castrucci MR; The InfluNet Study Group
    Expert Rev Vaccines; 2019 Nov; 18(11):1201-1209. PubMed ID: 31674847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.